Baxter 2021 Corporate Responsibility Report 16 Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Corporate Responsibility Commitment Introduction 2030 Corporate Responsibility Goals Cross-Cutting Commitments Our global Safer at Home awareness campaign educated patients and key stakeholders about home dialysis as an important therapy option during the COVID-19 pandemic and discouraged patients from delaying or opting out of therapy for fear of contracting the virus. In 2021, we continued to use social media channels to drive awareness globally and sponsor patient societies in delivering educational campaigns to their members and the general public. We also launched the MyKidneyJourney website, which was available in 28 countries as of the end of 2021, including many developing countries. This locally customizable website provides objective pre-dialysis education for patients and caregivers who are seeking additional disease and therapy information. Although clinicians can direct patients to the site, it does not require clinician referral, making it easy to access for patients and family members. In addition, we established our PD Ambassador Program in 2021. Through this program, we invited local opinion leaders to learn more about the current clinical benefits of PD, the role they play in shared decision making and patient choice, the importance of home dialysis during the COVID-19 pandemic and beyond, and digital health with the Sharesource remote patient management platform as a home therapy enabler. By the end of the year, we had established a group of 50 PD Ambassadors from 30 countries 2 who can consistently communicate the benefits of PD and advocate for its use. Advocating for Access to PD We support public policies, economic analyses and collaborations that advance access to PD. In 2021, we hosted a second International Home Dialysis Roundtable to continue work that this same group began in 2020 in response to the COVID-19 pandemic. This group continues collaborating to identify and help address the global challenges and opportunities related to access to home dialysis. These annual discussions are unique in that they represent a broad, multinational gathering of patient advocacy groups, clinical societies and industry representatives from 27 countries, including developing countries in Asia Pacific, Europe and other regions. While the roundtable was originally created to confront access-to-care challenges presented by the COVID-19 pandemic, the forum also identified the benefit of prioritizing and addressing—either individually or in collaboration—systemic challenges to home dialysis on an ongoing basis. This group was responsible for an important call to action, published in Kidney Medicine , and several advocacy outreach communications to policymakers throughout the year. Expanding Innovation and Services Innovation that meets the local needs of patients is critical to expanding access to care. With the proper awareness and education, we are working to expand access to our PD portfolio, including our digital health platform, in developing countries. For example, Sharesource remote patient management, our digital health platform, allows healthcare profession - als to securely view data from their patients’ recently completed home dialysis treatment, which is automati- cally collected after each automated peritoneal dialysis (APD) session. With real-time access to treatment data through Sharesource , healthcare professionals can remotely adjust patients’ home device settings without requiring additional trips to the clinic. Sharesource leads to other therapeutic benefits, including fewer dropouts, improved adherence, and improved patient-reported outcomes, as well as cost reduction. More than 50,000 Awareness and Training for PD Catheters In order to begin PD therapy, a patient must have a catheter inserted into their abdominal area. Completing this critical first step in a timely manner is a common barrier to PD therapy adoption and was especially challenging during the height of the pandemic when several countries deemed PD catheter insertion to be elective and suspended the procedure along with other elective surgeries. To support access to life-saving PD therapy, Baxter worked with healthcare professionals, medical societies and ministries of health globally to have catheter insertion procedures deemed an essential, non-deferable procedure, removing one barrier to patients beginning PD therapy. In 2021, we launched an educational campaign directed at nephrologists interested in placing catheters. The campaign included webinars, instructional videos, e-learning modules and interactive aids to raise awareness and encourage nephrologists to add PD catheter insertion to their practices. We also sponsored hands-on PD catheter training programs that trained nearly 400 nephrologists from 19 countries, including Algeria, Bahrain, Brazil, China, Colombia, Egypt, Ireland, Japan, Korea, Mexico, Morocco, Oman, Poland, Slovenia, South Africa, Sudan, Tunisia, Turkey and UAE. patients in 70 countries are connected to their clinicians via Sharesource . This platform and other innovations will continue to drive progress in this area. Visit our website for patient stories. MOVING FORWARD >> Increasing the number of patients we reach in any market is complex and multifaceted. For example, the COVID-19 pandemic continues to present significant challenges for patients with kidney disease, and we will continue to advocate for access to care in the home to reduce potential risks associated with kidney patients contracting the virus. We expect incremental growth toward achievement of our goal during the next few years as we continue to drive shared decision making and advocate for safe, effective home-based dialysis through a focus on awareness and education. We anticipate this multifaceted approach will eliminate barriers to care and accelerate our ability to reach patients over time. We will continue to prioritize flexibility and agility as we drive progress toward our long-term plans. Photo: The Sharesource remote patient management platform is available with our APD systems globally.